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Introduction
Juvenile nasopharyngeal angiofibroma (JNA) is rare, benign, 
but locally invasive tumour, with an incidence of 1:1 50 000.1 
It is one of the most common tumours of the nasopharynx, 
and accounts for 0.5% of all head and neck tumours.2-4 They 
are almost exclusively encountered in adolescent males. It 
is most common for JNAs to present with a classical triad 
of epistaxis, nasal obstruction and nasopharyngeal mass. 
The presence of other symptoms depends on the extent 
of tumour spread.5 Surgery is considered to be the gold 
standard JNA treatment.6 Other treatment options include 
radiation therapy (external beam), chemotherapy and 
hormone therapy antiandrogen (flutamide).6
JNAs are enormously vascular tumours and open surgical 
resection is associated with significant blood loss and 
postoperative morbidity. Advances in radiological imaging, 
better preoperative identification of the feeding vessel of the 
tumour and angiographic embolisation performed before 
surgery, together with hypotensive anaesthetic techniques 
and blood conservation strategies, have revolutionised 
the management of these tumours. Recently, endoscopic 
excision has been widely employed for the excision of 
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Abstract
Background: Juvenile nasopharyngeal angiofibroma (JNA) is a rare, benign, vascular tumour in adolescent males with 
potential life-threatening complications. Advances in endoscopic surgery, invasive monitoring and hypotensive anaesthesia 
have made JNAs amenable to endoscopic surgical resection. We present the anaesthetic management of endoscopic 
resection of 14 JNAs, together with a review.
Method: The medical records of patients who underwent endoscopic excision of JNAs within the last seven years were 
reviewed retrospectively. Information was collected and analysed with regard to demographics, preoperative evaluation, 
intraoperative management, complications and postoperative course. Fourteen patients were included in the study. If the 
surgery needed to be converted to open surgery, the patients were excluded from the study.
Results: The age of the patients ranged from 10-18 years. Two patients had preoperative embolisation of the feeding vessel. 
Standard anaesthesia induction technique, together with invasive monitoring, was used. Controlled hypotension (mean 
arterial pressure of 60 ± 5 mmHg) was achieved with the help of inhalational anaesthetics, vasodilators and beta blockers. 
Mean duration of surgery was 197.14 ± 77 minutes, and median blood loss was 500 ml (100- 4 300 ml). Seven patients were 
extubated in the operating room. The other seven patients remained intubated for 24 hours owing to extensive surgery with 
a risk of postoperative bleeding, and were monitored either in the postoperative care unit (five patients) or the intensive care 
unit (two patients). There was no significant morbidity or mortality in any of the patients. 
Conclusion: JNAs remain a challenge for anaesthesiologists because of excessive intraoperative bleeding. Anaesthetists 
should be aware of recent techniques to reduce tumour vascularity, such as embolisation of the feeding vessel and 
controlled hypotension. Invasive monitoring, together with multimodal blood conservation strategies, decreases blood loss 
and provides a clear field of vision for endoscopic surgery. 
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small- and medium-sized angiofibromas. Nasal endoscopy 
is minimally invasive and provides a magnified view of 
the tumour. It is also associated with less postoperative 
morbidity and a low recurrence rate.4
Despite the advances, JNAs continue to be a challenge 
because of vascularity, their proximity to vital neurovascular 
structures, and their difficult anatomic location. The major 
problem with endoscopic surgery is that even minimal 
bleeding can interfere with endoscopic vision. Thus, 
hypotensive anaesthesia is required to assist in decreasing 
blood loss and providing a bloodless, clear field to facilitate 
surgery.
Little literature are available on the anaesthetic management 
of the endoscopic resection of JNAs. We present this 
retrospective analysis of perioperative anaesthetic 
management of patients who underwent endoscopic 
resection for JNAs at our institute over the last seven years, 
and reviewed the literature in the light of current evidence.
Method
The medical records of patients with JNAs who had 
undergone endoscopic excision of their tumours within the 
last seven years were reviewed retrospectively. Data were 
collected on the patient’s age, sex, presenting symptoms, 
preoperative investigations, preoperative imaging and 
embolisation, and staging of the tumours according to size. 
Anaesthetic charts were reviewed and detailed information 
collected on the airway examination, associated systemic 
illness, anaesthetic technique, intraoperative monitoring, 
blood conservation strategy, deliberate hypotension 
technique, duration of surgery, blood loss, intraoperative 
fluid management, blood transfusion and any other 
complications. In addition, information 
on the postoperative period was also 
collected. Descriptive quantitative 
data were presented as mean ± 
standard deviation range of values.
Results 
The demographic profile of the 
patients is given in Table I. All 14 
patients were male, with a mean age 
of 14.7 ± 2.5 years (10-18 years) and 
a mean weight of 44.93 ± 11.7 kg (28-
65 kg). Unilateral nasal obstruction 
was the presenting symptom in 13 
patients, and one patient presented 
with epistaxis. Five patients had a 
history of snoring and two patients 
were complete mouth breathers. 
The diagnosis of JNAs was made 
from the history and a computerised 
tomography (CT) scan finding 
pertaining to the nasal and paranasal 
sinuses. Tumours were classified according to Radkowski’s 
staging7 (Table II). Patients were categorised as Radkowski’s 
stage I or II. None of the patients received preoperative 
blood transfusion, had other systemic illnesses, nor a 
predictable difficult airway. (The modified Mallampati 
score was between 1 and 2). Apart from standard routine 
laboratory tests (haemogram, prothrombin time, and liver 
and renal function tests), a CT scan, magnetic resonance 
imaging (MRI) and an angiogram were performed. None of 
the patients received adjuvant radiotherapy or hormonal 
therapy in the preoperative period. Two underwent 
embolisation of the feeding artery 24-48 hours before 
surgery to reduce intraoperative bleeding.
After a thorough preanaesthetic evaluation, patients were 
premedicated with an anxiolytic agent (benzodiazepine) 
the night before and on the morning of the surgery. 
In the operation room, routine standard monitors [an 
electrocardiogram (ECG), oxygen saturation (SpO2) and 
noninvasive blood pressure (NIBP)] were applied, and 
base line values recorded. Anaesthesia was induced with 
intravenous fentanyl (1-2 µg/kg) and propofol (1-2 mg/kg). 
Neuromuscular blockade was achieved with vecuronium 
(0.1 mg/kg). After securing the oral cuffed endotracheal 
tube, a throat pack was inserted. Two large-bore (16- or 
14-gauge) peripheral venous accesses were secured, either 
in the upper or lower limb, depending on the size of the veins. 
The patients were placed supine, in a 30-degree, reverse 
Trendelenburg position, and the lower limbs elevated by 
placing pillows below their knees. Cephalic or basilic veins 
were used to measure central venous pressure (CVP), with 
a mean target CVP of 10 cm of water from a peripherally 
inserted central venous catheter. An arterial catheter was 
placed in the dorsalis pedis artery in 12 patients, and 

















1 14 40 I + - 13.5 IIc
2 14 32 I - - 12.8 Ib
3 16 45 I - - 13.7 Ib
4 12 40 II - - 12.4 Ib
5 12 33 II - - 11.1 IIa
6 15 45 I - - 14.6 IIc
7 18 55 II + + 14.9 Ib
8 13 28 I - - 10.7 Ib
9 15 65 II - + 13.5 Ia
10 17 45 I - - 13.1 Ia
11 19 60 II - + 13.6 Ia
12 14 49 II - + 12.9 Ia
13 17 60 I - + 13 IIc
14 10 32 I + - 13.7 Ia
+: mouth breathing present, snoring present
-: mouth breathing absent, snoring absent
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in the radial artery in two, for invasive blood pressure 
measurements. A urinary catheter was inserted and axillary 
skin temperature measured with a skin temperature probe. 
An in-line warmer was used to infuse warm fluids. Before 
the start of surgery, the anaesthesia workstation was moved 
near the patients’ feet. Anaesthesia was maintained, either 
with isoflurane or propofol, and neuromuscular blockade 
guided by neuromuscular monitor. Intraoperative analgesia 
was administered with boluses of fentanyl (0.5-1 µg/kg) to 
six patients, and boluses of morphine (50-100 µg/kg) to 
eight patients. 
The mean duration of surgery was 197.14 ± 77.7 minutes 
(60-360 minutes), and median blood loss, 500 ml (100- 
4 300 ml). Deliberate hypotension was provided to patients 
with a mean target arterial blood pressure of 60 ± 5 mmHg. 
The drugs used to provide deliberate hypotension, strategies 
employed to decrease blood loss, the total blood loss, and 
the amount of fluid and blood product transfused, are given 
in Table III. Of four patients who required blood transfusion, 
only one needed blood products (fresh frozen plasma and 
packed platelets) to be transfused.The urine output was 
maintained between 0.5 ml/kg/hour and 1.5 ml/kg/hour 
in patients. None of them developed hypothermia. Two 
patients experienced intraoperative hypotension. Patient 
number 3 and 13 were revision cases. The mean arterial 
pressure was less than 55 mmHg because of increased 
blood loss in them. As an institutional practice, endoscopic 
resection is not carried out in any revision surgeries for 
JNAs. There were no other intraoperative complications. 
Table II: Radkowski’s staging
Stage Extent of the tumour
Ia Tumour is limited to the nasal cavity and nasopharynx
Ib Tumour is in the nasal cavity, extending into one, or more, 
paranasal sinuses
IIa There is minimal extension of the tumour through the 
sphenopalatine foramen into the pterygopalatine fossa
IIb There is full occupation of the pterygopalatine fossa, 
with or without superior extension, through erosion of the 
orbital bones
IIc Tumour extends into the infratemporal fossa, or is 
posterior to the pterygoid plates
IIIa There is skull base erosion and minimal intracranial 
extension
IIIb There is extensive intracranial extension, with or without 
extension into the cavernous sinus
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1 270 - + NTG infusion + + 500 3 000 -
2 60 - + Isoflurane + + 200 1 500 -
3 240 - + NTG infusion + + 3 500 7 000 4 RBC
4 90 - + Isoflurane + + 100 1 000 -
5 120 - + Esmolol 
infusion
+ + 500 1 000 -
6 165 - + Isoflurane + + 1 300 3 000 2 RBC
7 195 + + Propofol 
infusion
+ + 400 1 500 -
8 195 - + Isoflurane + + 1 600 2 500 2 RBC
9 210 - + Isoflurane + + 600 4 000 -
10 255 - + Esmolol 
infusion
+ + 500 2 500 -
11 150 - + Isoflurane 
and labetolol 
boluses
+ + 700 2 500 -
12 210 + + Isoflurane + + 300 2 500 -
13 360 - + Isoflurane + + 4 300 7 000 4 RBC




+ + 250 2 500 -
PICC: peripherally inserted central catheters, mins: minutes, NP: nonpharmacological, NTG: nitroglycerin, P: pharmacological, RBC: red blood cells
*: reverse Trendelenburg position
+: Preoperative embolisation, reverse Trendelenburg performed, bipolar cautery used, and arterial line for invasive monitoring placed
-: Preoperative embolisation, reverse Trendelenburg not performed, bipolar cautery not used, and arterial line for invasive monitoring not placed. No red blood cells were transfused
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At the end of the surgery, anterior nasal packing was carried 
out. Three of the patients required a posterior nasal pack. 
Before reversal of the residual neuromuscular blockade, 
the throat pack was removed and laryngoscopic guided 
oral suction performed. The trachea was extubated in the 
operation room in seven patients when they were fully awake, 
and supplemental oxygen provided in the post-anaesthestic 
care unit (PACU). The remaining seven patients were kept 
intubated electively owing to prolonged surgery and the 
risk of re-bleeding. Of these, five were monitored in the 
PACU and oxygen provided by a T-piece. Two patients were 
shifted to the intensive care unit (ICU), one was electively 
ventilated because of massive blood loss and the risk of 
re-bleeding, while the other received continuous positive 
airway pressure (CPAP). Morphine 1mg/hour infusion was 
started for postoperative pain, sedation and tube tolerance 
in the intubated patients.
Information on the postoperative course taken is provided in 
Table IV. Patients received dexamethasone (0.1 mg/kg) intra-
operatively on induction of anaesthesia and postoperatively 
(6-8 hourly), to minimise tissue oedema. Extubation was 
planned 12-24 hours after surgery, after confirming the 
absence of active bleeding and conducting a positive 
leak test with the cuff deflated. Three patients who had a 
posterior nasal pack in situ required general anaesthesia 
for pack removal and airway protection. One patient had 
300 ml of blood loss during pack removal. The trachea 
was extubated in these patients after removal of the pack 
under anaesthesia. No other postoperative complication 
was noted in any of the patients. Patients were discharged 
between five and eight days after surgery. During follow-up, 
none of them had tumour recurrence until January 2013.
Discussion 
JNAs are the most common 
benign neoplasm of the naso-
pharynx.2-4 Despite their benign 
nature, they have a locally 
destructive growth pattern and 
can cause bone erosion. JNAs 
can result in potentially life-
threatening complications, such 
as fatal epistaxis, intracranial 
extension and intraoperative 
massive blood loss.4 The tumours 
consist of fibrotic and vascular 
elements. However, the vascular 
elements lack elastic lamina and 
elastic fibres, hence the vessels 
are unable to contract, resulting 
in severe bleeding during their 
removal.6,8 Management of JNAs 
is a challenge owing to their 
rich vascular supply, complex 
adjacent anatomical structures 
and aggressive growth pattern. 
JNA are exclusively found in the young male population 
(10-24 years of age). The most common presentation is 
unilateral nasal obstruction, followed by epistaxis.9 Most 
patients do not have any associated systemic illness. A 
CT scan and MRI play a critical role in proper evaluation 
of the tumour. A CT scan provides information on the bony 
details, whereas MRI is crucial in supplying soft tissue-
related information and the position of the tumour with 
regard to critical structures, such as the carotid artery and 
cavernous sinus.6 An angiography provides information on 
blood supply to the tumour, and also helps in decisions on 
the feasibility of preoperative embolisation. Branches of 
the internal maxillary artery, and a branch of the external 
carotid, provide the major blood supply to most JNAs, but, 
as these tumours grow, they may also develop a vascular 
supply from branches of the ipsilateral internal carotid artery 
and contralateral external carotid artery.10,11 In the present 
study, a CT scan, MRI and angiography were performed 
in patients for the preoperative evaluation. Preoperative 
details of the radiographic imaging help when planning 
anaesthesia.
Staging of JNAs is mainly based on the extent of the tumour 
and the amount of intracranial extension. Radkowski’s 
classification is the most accepted one and has better 
predictability with regard to morbidity and prognosis. 
All of the tumours in the present study were stage I or II 
(Radkowski’s classification). Patients with Radkowski’s 
stage III tumours are not good candidates for endoscopic 
surgery.10
Primarily, treatment of JNA is surgical resection though other 
adjunctive therapies, e.g. radiation therapy, chemotherapy 











Blood loss during 
pack removal
1 + Face mask PACU - Minimal
2 + Face mask PACU - Minimal
3 - IPPV ICU + (300 ml)
4 + Face mask PACU - Minimal
5 - CPAP ICU - Minimal
6 + Face mask PACU - Minimal
7 + Face mask PACU - Minimal
8 - T-piece PACU - Minimal
9 - T-piece PACU - Minimal
10 - T-piece PACU + Minimal
11 + Face mask PACU - Minimal
12 - T-piece PACU - Minimal
13 - T-piece PACU + Minimal
14 + Face mask PACU - Minimal
CPAP: continuous positive pressure ventilation, GA: general anaesthesia, ICU: intensive care unit, IPPV: intermittent positive pressure 
ventilation, OR: operating room, PACU: post-anaesthetic care unit
+: Yes, i.e. the patient was extubated in the operation room, and the pack was removed under general anaesthetic
-: No, i.e. the patient was not extubated in the operation room, and the pack was not removed under general anaesthetic
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and hormone therapy.6 External beam radiation is 
generally reserved for larger and/or irresectable and life-
threatening tumours. Radiation may lead to complications 
such as growth retardation, temporal lobe radionecrosis, 
keratopathy and potential carcinogenic side-effects.6,12,13 
Chemotherapy is not very effective.6 As JNA growth is 
androgen-dependent, antiandrogen therapy decreases 
the size and vascularity of the tumour.14 Oestrogen is not 
used because of its feminising side-effects and the risk 
of cardiovascular complications.12,14 There have been 
conflicting recommendations in different studies with 
regard to flutamide, an androgen receptor blocker, which 
has been found to have unproven efficacy. However, it is 
of particular interest in partial volume reduction.14-16 None 
of the patients in this study had adjunctive therapy for 
tumour size reduction. Anaesthesiologists must be aware 
of these treatment modalities and their side-effects. Prior 
radiation therapy makes laryngoscopy difficult owing to 
the noncompliant fibrosed submandibular space, and 
can lead to significant postoperative oedema owing to 
obliteration of the lymphatics. Patients on radiotherapy are 
more susceptible to infection and bleeding during airway 
manipulation because of epidermities and oral mucositis.17
Preoperative selective arterial embolisation of the feeding 
vessels significantly decreased intraoperative blood 
loss and facilitated the resection of larger tumours.18,19 
Embolisation is typically performed 24-48 hours prior to 
resection, as after several days the contralateral vessels 
may became the major contributor to the tumour. The 
transarterial technique of embolisation is associated with a 
significant risk of complications, such as numbness, facial 
palsy, strokes and occlusion of the ophthalmic artery.6,12 
Recently, the injection of embolising material by direct 
tumoural puncture was advocated as it produces a greater 
degree of tumour devascularisation than the transarterial 
technique.20 Apart from numbness, facial palsy, strokes 
and occlusion of the ophthalmic artery, minor side-effects 
like pain, increased leucocyte count and fever are more 
common, and may mimic acute infection in the preoperative 
period. In this study, two of the 14 patients, both with a 
Radkowski’s stage I tumour, underwent preoperative 
embolisation of the feeding vessel which led to a significant 
decrease in blood loss of 400 and 300 ml (total blood loss 
was 14 850 ml). Fear of significant complications, and 
chances of incomplete resection of the tumour because of 
blunting of borders after embolisation, are major concerns 
in the routine preoperative use of embolisation of JNAs.21,22 
There have been studies in which JNAs have been operated 
endoscopically, without significant bleeding in the absence 
of preoperative embolisation.23,24 The authors at our 
centre prefer surgical ligation of the feeding maxillary and 
sphenopalatine arteries, and consider it to be as effective 
as preoperative embolisation.
The open surgical approach is associated with significant 
intraoperative and postoperative morbidity because of 
massive blood loss. The endoscopic approach overcomes 
the disadvantages of the open approach, and provides 
excellent magnified tumour visualisation. In addition, it also 
reduces intraoperative blood loss, length of hospital stay 
and recurrence rate.6 The present study was in accordance 
with previous reports which state that early-stage JNAs 
(stage I and II, and some stage III) can be removed using 
the endoscopic approach.6,23 Tumours with significant 
intracranial spread cannot be resected endoscopically, and 
preferably, this is avoided in revision surgery.
A haemodynamically stable patient, during and after 
surgery, is the main goal of anaesthetists. The prime 
anaesthetic concern in the resection of JNAs is prevention 
of the aspiration of blood, minimisation of blood loss and 
prevention of airway obstruction in the postoperative period 
owing to surgical manipulation. Ezri et al25 have advocated 
rapid sequence induction to prevent aspiration during 
induction. In the present study, patients were induced in the 
standard manner, without complications. Rapid sequence 
induction may be preferred in patients with active epistaxis. 
In this study, after securing the cuffed endotracheal tube, 
a throat pack was inserted as an additional measure to 
prevent aspiration. Throat packs should be removed at 
the end of surgery before extubation to prevent airway 
obstruction.
In addition to standard routine monitoring (an ECG, 
SPO2, NIBP and end-tidal carbon dioxide), invasive 
haemodynamic monitoring is essential in providing safe 
hypotensive anaesthesia. As access to the neck veins 
is limited, either the basilica or cephalic, or subclavian or 
femoral vein, can be cannulated for CVP monitoring. In the 
current study, cubital fossa veins were used to monitor CVP. 
Similarly, either the radial artery or dorsalis pedis artery can 
be used for invasive blood pressure monitoring. In order to 
be able to rapidly transfuse fluid and blood products, large-
bore cannulae should be secured. Lower limb veins may be 
preferred for venous access because they are accessible 
intraoperatively as upper limbs are kept by the patient’s side 
and are under the surgical drapes. Proper extension lines 
should be connected if upper limb veins are used. 
Apart from preoperative embolisation in two patients, other 
blood conservation strategies used in this group were the 
reverse Trendelenburg position, deliberate hypotension 
and use of high-power bipolar diathermy. The reverse 
Trendelenburg position deviates blood away from the 
surgical field because of gravity, and thus decreases blood 
loss.25,26 It also facilitates better surgical exposure. The lower 
limbs should be elevated and the knees kept at heart level 
to ensure optimal venous return. One major concern with 
this position is the risk of venous air embolism (VAE), which 
has a incidence of 6-30% in the semi-sitting position.26 
Euvolaemia should be maintained and the surgical field 
flushed with saline by the surgeon to prevent VAE. End-tidal 
carbon dioxide was monitored in the patients, and in the 
present study, there was no significant incidence of VAE.
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Deliberate hypotension, with a mean target arterial pressure 
of 60 ± 5 mmHg, was used in this study. Inhalational 
anaesthetic, vasodilators and beta blockers were effectively 
employed for this purpose. The disproportionately severe 
blood loss in two cases (case 3 and 13) occurred because 
of unfavourable patient factors, which caused difficult 
endoscopic access. Both cases had been operated upon 
previously. The authors abandoned endoscopic excision in 
the revision cases. 
Similar to the previous study by Ezri et al,25 a higher 
concentration of inhalational anaesthetic (isoflurane in 1.5-
2.5% dial setting) was used in eight patients for controlled 
hypotension, of which three required blood transfusion. 
Propofol, nitroglycerin and esmolol were also given to two 
patients. In addition to primary therapy, labetolol boluses 
(propofol and isoflurane) were also used in two patients. The 
literature does not support any particular agent over another 
for this purpose. A most recent satisfactory and preferred 
technique is a combination treatment of remifentanil, 
with either propofol or an inhalation agent (isoflurane, 
desflurane or sevoflurane), at clinical concentrations.27 
Total intravenous anaesthesia using propofol and 
remifentanil was found to provide a drier surgical field than 
balanced general anaesthesia with esmolol in children 
undergoing functional endoscopic sinus surgery. However, 
both techniques are safe and effective in controlling 
hypotension.28 When compared with the normotensive 
state, direct-acting vasodilators, such as nitroglycerin and 
nitroprusside, beta-adrenoceptor antagonists and calcium-
channel antagonists, have clearly demonstrated a reduction 
in blood loss with controlled hypotension, but there are 
potentially dangerous complications with each agent (toxic 
metabolites, myocardial depression and arrhythmias).25,27
Use of endoscopic bipolar cautery by surgeons has been 
found to be an effective adjunct to other techniques with 
regard to reducing blood loss.26 In addition to these modalities, 
other techniques that can be used to reduce the need for 
allogenic transfusion are autologus blood transfusion, acute 
normovolumeic haemodilution, intraoperative red blood cell 
salvage and intraoperative use of fibrin glue. As the surgery 
is performed on an priority basis, enough time may not be 
available to administer erythropoietin and to build up the 
haemoglobin and autologous blood collection. However, 
acute normovolemic haemodilution can be performed post 
induction for extensive angiofibromas that require massive 
blood transfusion. Red blood cell salvage is commonly used 
for procedures in which major blood loss is anticipated. 
However, its use for endonasal surgeries is controversial 
because the site of surgery and blood collection can be 
contaminated by the nasal flora.29 Use of an intratumoural 
injection of fibrin glue has been described in a few case 
reports.26 
 In comparison to the study by Ezri et al,25 in which the open 
surgical technique was used, and the mean loss was 4 800 
± 1 600 ml, the patients in this study experienced a median 
blood loss of 500 ml, but endoscopic surgical resection was 
used these cases. Similarly, only 28.5% of patients (four) 
required blood transfusion, by comparison with 100% of 
patients in a previous study.25 Although ordering at least 10 
units of blood on standby in the preoperative period for JNA 
resection has been advocated, in the authors’ opinion, such 
amounts may not be required with the use of multimodal 
blood conservation techniques during endoscopic 
resection, as was found in this study. Apart from blood 
loss, two patients experienced intraoperative hypotension 
because of the blood loss, which was managed by stopping 
the hypotensive measures, and administering a rapid 
infusion of fluid and blood and boluses of ephedrine. No 
other complications were experienced by patients in this 
study.
At the end of surgical procedure, a decision to extubate the 
trachea was taken only after consulting with the surgeon. 
Massive blood loss, extensive surgical dissection, suspicion 
of residual tumour, non-specific oozing of blood from the 
surgical site and in situ postnasal packs are conditions that 
preclude safe extubation. In such cases, the endotracheal 
tube is left in place for at least 24 hours, with close 
monitoring of the airway and haemodynamic status. In a 
study by Ezri et al,25 tracheal extubation was deferred in 
patients (100%) who had open surgical resection of JNAs 
(eight), whereas two patients who underwent endoscopic 
resection were extubated immediately after surgery. By 
contrast, in the current study, extubation was delayed in 
only 50% of the patients (seven). Endoscopic resection of 
JNAs leads to less intraoperative bleeding and extensive 
surgical trauma. Hence, there is more chance of tracheal 
extubation in the operating room immediately after surgery. 
In the present group, five patients were kept in the PACU 
with the tube in situ, and two were transferred to the ICU. 
In the ICU, one patient required elective ventilation because 
of symptomatic anaemia, massive blood loss and related 
complications, while the other required CPAP owing to poor 
respiratory effort. All of the patients were extubated 24 hours 
postoperatively after ensuring haemostasis and conducting 
a positive leak test around the deflated cuff. The cuff leak 
test helped to identify patients at risk of developing post-
extubation stridor due to laryngeal oedema. However, the 
discriminatory power of the cuff leak test is highly variable. 
While the presence of a cuff leak predicts successful 
extubation, a failed cuff leak test is not an accurate predictor 
of post-extubation stridor, and if used as a criterion for 
extubation, may lead to unnecessarily prolonged intubation, 
or to needless tracheostomy.30,31 
Bleeding can occur during removal of the pack, and it 
is advisable to conduct the procedure under general 
anaesthesia, with monitoring and resuscitation equipment 
nearby. In this study, three patients had a posterior nasal 
pack because of non-specific oozing and underwent 
delayed extubation after 24 hours under anaesthesia. One 
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patient had 300 ml of blood loss during pack removal, which 
was controlled with bipolar cautery. Pack removal in the 
other patients was uneventful. Pain relief postoperatively 
of morphine 1 mg/hour infusion and paracetamol 1 g 
three times daily was given to intubated patients. Fentanyl 
boluses of 1-2 µg/kg were given to extubated patients, if 
necessary.
Conclusion
Despite advances in surgical and anaesthetic techniques, 
surgery for JNA remains a challenge for anesthesiologists. 
The latter should be aware of advances in the management 
of these tumours, the latest drugs, monitoring modalities, 
blood conservation strategies, as well as anaesthetic 
techniques, which can help to provide optimal perioperative 
care of these patients. Preoperative embolisation and 
controlled hypotension are major factors used to decrease 
blood loss during endoscopic resection of JNAs. Multimodal 
blood conservation techniques, in combination with 
hypotensive anaesthesia, should be used to decrease blood 
loss and provide a drier field during endoscopic resection 
of a JNA. The authors recommend that early-stage JNAs 
(stage I and II, and some stage III) should be removed using 
the endoscopic approach, and that tumours with significant 
intracranial spread must not be resected endoscopically. 
Preferably, endoscopic resection should be avoided in 
revision surgery.
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